<DOC>
	<DOC>NCT02007590</DOC>
	<brief_summary>To investigate whether high frequency airflow oscillation (HFAO), delivered using Aerosure, increases six minute walk distance (6MWD) and reduces exertional breathlessness in patients with severe chronic obstructive pulmonary disease (COPD).</brief_summary>
	<brief_title>Aerosure and Six Minute Walk Distance in Severe COPD</brief_title>
	<detailed_description />
	<criteria>Stable severe COPD (FEV1 &lt; 50% predicted) Modified MRC dyspnoea score 2 or greater At least 10 pack year smoking history Able to mobilise independently Contraindications to spirometry [1] Contraindications to clinical exercise testing [2] Contraindications to HFAO (see section A.6.3b)) Resting SpO2&gt;88% on air or on patient's usual oxygen prescription Systolic arterial blood pressure (ABP) &gt;200mmHg, diastolic ABP &gt;100 mmHg 1. Cooper, B.G., An update on contraindications for lung function testing. Thorax, 2010. 2. ATS/ACCP Statement on Cardiopulmonary Exercise Testing. Am. J. Respir. Crit. Care Med., 2003. 167(2): p. 211277.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>